cisapride


Also found in: Wikipedia.

cisapride

Propulsid® GI disease An agent that ↑ lower esophageal sphincter pressure and for nocturnal therapy of GERD Adverse effects Headache, diarrhea, abdominal pain, nausea, rhinitis, constipation. See GERD.

cisapride

A prokinetic drug that aids in stomach emptying and helps to relieve heartburn (reflux oesophagitis). A trade name is Prepulsid.

cisapride (sis´əprīd´),

n brand name: Propulsid;
drug class: oral prokinetic;
action: enhancement of acetylcholine release;
uses: symptomatic treatment and prophylaxis of nocturnal heartburn caused by gastroesophageal reflux disease.

cisapride

a substituted benzamide, similar to metoclopramide, which stimulates gastrointestinal motility. Used as an antiemetic by promoting gastric emptying.
References in periodicals archive ?
Cisapride is a drug used to increase gastrointestinal motility.
16 Compared to metoclopramide and cisapride, domperidone was safer and extensively applied.
Two different dosages of cisapride in treatment of reflux esophagitis: a double blind comparison with ranitidine.
Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastrooesophageal reflux.
Serotonin antagonists like ondansetron and cisapride have also been found to be effective in CBS.
Drug Interactions: Co-administration of cisapride, pimozide, quinidine, dofetilide, levacetylmethadol (levomethadyl), felodipine, oral midazolam, nisoldipine, triazolam, lovastatin, simvastatin, ergot alkaloids such as dihydroergotamine, ergometrine (ergonovine), ergotamine and methylergometrine (methylergonovine) or methadone with ONMEL[TM] is contraindicated.
After referral to the Phoenix Zoo, treatment of the condors with the cholinergic agonists cisapride (0.
The FDA approved cisapride for the treatment of gastro-esophageal reflux disorder in 1993.
The ministry decided last week to ban the sale, distribution and manufacture of nimesulide's paediatric formulation along with cisapride, phenylpropanolamine, human placenta extract and sibutramine and R- sibutramine.
The involvement of this receptor subtype is confirmed by a clinical trial where STW 5 showed non-inferior efficacy to the standard prokinetic cisapride, a 5-[HT.
interventions for constipation in Adult Patients With cancer Recommended for Practice None Likely to Be Effective Opioid-induced constipation * Prophylactic bowel management regimen * Opioid rotation Persistent constipation * Polyethylene glycol 3350 (PEG 3350) * Stimulant or osmotic laxatives Benefits Balanced With Harms Opioid-induced constipation< * Oral naloxone, an opioid receptor antagonist Effectiveness Not Established See Figure 2 Not Recommended for Practice Managing opioid-induced constipation * Nalmefene * Naltrexone Constipation in adult patients not specific to opioids * Cisapride * Corn syrup * Dantron[TM] (chrysazin; 1,8-dihydroxyanthraquinone, Hexal Pharma) Note.